Teladoc rises after Citron report calls it a “coiled spring”
Teladoc, the embattled pandemic-era darling, rose about 15% on Monday and is up another 4.7% in premarket trading on Tuesday after Citron Research published a bullish report on the company.
The fact that more of Teladoc’s services — especially BetterHelp, its biggest cash cow — will soon potentially be covered by insurance could reverse the company’s declining revenues, the research firm said: “This isn’t incremental — it’s transformational.”
The cheery report breathed life into Teladoc, which is still down 17% this year. It recently appointed a new CEO after the abrupt departure of its longtime leader in April.
The stock peaked at about $300 a share in early 2021. On Monday, it closed at $7.89.
$TDOC — the largest telehealth company on earth — is a coiled spring at a $1.2B market cap. And CEO just flipped the script
— Citron Research (@CitronResearch) June 23, 2025
Teladoc owns BetterHelp, the #1 brand in online therapy. But until now, BetterHelp was cash-pay only — and that crushed conversions. Every year, millions…
$TDOC — the largest telehealth company on earth — is a coiled spring at a $1.2B market cap. And CEO just flipped the script
— Citron Research (@CitronResearch) June 23, 2025
Teladoc owns BetterHelp, the #1 brand in online therapy. But until now, BetterHelp was cash-pay only — and that crushed conversions. Every year, millions…
